The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
103591566 10359156 6 F 201108 20160902 20140804 20160915 EXP PHHY2014BR092278 NOVARTIS 62.28 YR F Y 52.00000 KG 20160915 MD BR BR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
103591566 10359156 1 PS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 20 MG, QMO, EVERY 28 DAYS U 21008 20 MG VIAL /month
103591566 10359156 2 C DECADRON DEXAMETHASONE 1 Unknown 2 DF, QD (1 TABLET AT 07:15 AM AND 1 TABLET AT 7 PM) 0 2 DF TABLET QD
103591566 10359156 3 C HIDANTAL PHENYTOIN SODIUM 1 Unknown 1 DF, QD 0 1 DF QD
103591566 10359156 4 C RIVOTRIL CLONAZEPAM 1 Unknown 1 DF, QD (AT 08:40 PM) 0 1 DF QD
103591566 10359156 5 C RIVOTRIL CLONAZEPAM 1 0
103591566 10359156 6 C CRESTOR ROSUVASTATIN CALCIUM 1 Unknown 0
103591566 10359156 7 C CARVEDILOL. CARVEDILOL 1 Unknown 2 DF, QD (1 TABLET AT 8 AM AND 1 TABLET AT 8 PM) 0 2 DF TABLET QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
103591566 10359156 1 Neuroendocrine tumour
103591566 10359156 2 Seizure
103591566 10359156 3 Product used for unknown indication
103591566 10359156 4 Anxiety
103591566 10359156 5 Sleep disorder
103591566 10359156 6 Blood triglycerides abnormal
103591566 10359156 7 Cardiac disorder

Outcome of event

Event ID CASEID OUTC COD
103591566 10359156 OT
103591566 10359156 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
103591566 10359156 Abdominal adhesions
103591566 10359156 Abdominal hernia
103591566 10359156 Alopecia
103591566 10359156 Cardiac disorder
103591566 10359156 Cardiomegaly
103591566 10359156 Chordae tendinae rupture
103591566 10359156 Clavicle fracture
103591566 10359156 Concomitant disease aggravated
103591566 10359156 Depressed mood
103591566 10359156 Diabetes mellitus
103591566 10359156 Dizziness
103591566 10359156 Face injury
103591566 10359156 Fall
103591566 10359156 Fear of falling
103591566 10359156 Feeding disorder
103591566 10359156 Gastrointestinal carcinoma
103591566 10359156 Hypertrichosis
103591566 10359156 Hypoaesthesia
103591566 10359156 Immobile
103591566 10359156 Inflammation
103591566 10359156 Limb discomfort
103591566 10359156 Malaise
103591566 10359156 Malignant neoplasm progression
103591566 10359156 Memory impairment
103591566 10359156 Metastases to central nervous system
103591566 10359156 Nausea
103591566 10359156 Seizure
103591566 10359156 Skin irritation
103591566 10359156 Visual impairment
103591566 10359156 Weight decreased
103591566 10359156 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
103591566 10359156 1 2011 0
103591566 10359156 2 2013 0
103591566 10359156 3 2013 0
103591566 10359156 4 2013 0
103591566 10359156 7 2013 0